SCA
AGN

Strategic Capital Alternatives’s Allergan plc AGN Stock Holding History

Strategic Capital Alternatives’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1.31M Buy
4,804
+3,734
+349% +$1.15M 0.28% 108
2015
Q2 		$325K Sell
1,070
-60
-5% -$17.9K 0.08% 159
2015
Q1 		$336K Buy
+1,130
New +$322K 0.08% 139
2014
Q4 		– Sell
-1,110
Closed -$268K – 374
2014
Q3 		$268K Buy
+1,110
New +$248K 0.09% 118

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Strategic Capital Alternatives's AGN Position: Q3 2015 in Review

Strategic Capital Alternatives increased its Allergan plc (AGN) stake by 349% in Q3 2015, buying an estimated $1.15M and bringing the position to 4,804 shares worth $1.31M. The position accounts for 0.28% of the portfolio, ranked #108.

Strategic Capital Alternatives first reported a position in AGN in Q3 2014 and has held it in 4 quarters since. 1,057 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Strategic Capital Alternatives held 4,804 shares of Allergan plc worth $1.31M as of Q3 2015.
  • Strategic Capital Alternatives bought 3,734 Allergan plc shares in Q3 2015, an estimated $1.15M.
  • Allergan plc made up 0.28% of Strategic Capital Alternatives's portfolio in Q3 2015, its #108 holding.
  • Strategic Capital Alternatives first reported a position in Allergan plc in Q3 2014 and has held it in 4 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.